Coronavirus Today

 / June 29th, 2022

Eliminating fake vaccine news with pharmacist, nurse, and physician review.

Jun 29 • 11:11 am CDT
Indiana-based Eli Lilly and Company announced today a modified purchase agreement with the U.S. government to supply an additional 150,000 doses of bebtelovimab for approximately $275 million. The existing U.S. government supply of bebtelovimab monoclonal antibodies... READ →
Jun 24 • 12:12 pm CDT
Valneva SE today announced that the European Commission (EC) had granted marketing authorization in Europe for Valneva's inactivated whole-virus COVID-19 vaccine, VLA2001, for use as primary vaccination in people from 18 to 50 years of age... READ →
Jun 18 • 3:17 pm CDT
The Gamaleya National Research Center of Epidemiology and Microbiology recently announced that Vaccines, the leading peer-reviewed medical journal, had published the results of a joint study showing the two-dose Sputnik V vaccine is 97% effective against... READ →
Jun 15 • 8:09 am CDT
New York-based Pfizer Inc. recently shared data from the Phase 2/3 EPIC-SR study evaluating the use of PAXLOVID™ in patients at standard risk for developing severe COVID-19. In an updated analysis through December 2021, Paxlovid showed... READ →
Jun 6 • 4:28 pm CDT
Increasing evidence suggests SARS-CoV-2 coronavirus antibody levels are correlated to immune protection, which is useful when choosing vaccine types and monitoring its decay over time. But its quantitation relies on intensive laboratory techniques. On May 3,... READ →

For more articles, try our search.